Clinical Trial Update: Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completed Phase 1/2 study of IDEC-114 in Non-Hodgkin lymphoma, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• IDEC-114

Snippet

Sponsor: Biogen | Conditions: Non-Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: COMPLETED